Collaboration for Europe
VAC4EU (Vaccine monitoring Collaboration for Europe) is the sustainability solution of the ADVANCE project which was funded by the Innovative Medicines Initiative from October 2013- March 2019. VAC4EU implements the ADVANCE vision, system and blueprint and enables robust and timely evidence-generation on the effects of vaccines in a collaborative manner in Europe for use by citizens, health care professionals, public health organisations and regulatory agencies. VAC4EU is a multi-stakeholder international association with a study network to run studies and an open community for scientific debate. Read more…
If you want the study network to conduct a study for you, simply contact firstname.lastname@example.org. We will get in touch to assess your requirements and activate the study network.
If you are interested in conducting a study on vaccine coverage, benefits and/or risks, here are some online resources to help you on get started:
ACCESS: vACcine Covid-19 monitoring readinESS
VAC4EU is proud to partner in the ACCESS project (vACcine Covid-19 monitoring readinESS) that is funded by the European Medicines Agency to ensure that a European infrastructure will be in place to effectively monitor COVID-19 vaccines in the real world, once these are authorised in the European Union.
the IT infrastructures for ACCESS
Catalogue of organizations in each EU country that may access data (vaccines, hospital or electronic health care records) and be willing to participate in studies to monitor the coverage, safety and effectiveness of COVID-19 vaccines.
Opportunity to vaccine manufacturers and public institutions to access data & expertise in Europe to conduct studies according to VAC4EU governance & conduct by contacting the VAC4EU secretariat (email@example.com)
Monthly webinars to discuss scientific topics: please register if you wish to join